Ryan Zimmerman
Stock Analyst at BTIG
(4.42)
# 248
Out of 4,826 analysts
174
Total ratings
57.43%
Success rate
13.83%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $87 → $91 | $70.49 | +29.10% | 11 | Dec 12, 2024 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $39.24 | +68.20% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $294.17 | -8.22% | 19 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $86.86 | +71.54% | 10 | Nov 26, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $535 → $561 | $531.82 | +5.49% | 17 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $381.56 | +3.26% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $1.26 | +693.65% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $97.38 | +8.85% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $13.28 | - | 6 | Oct 7, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $134 → $126 | $90.48 | +39.26% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $69.37 | +44.15% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $66.89 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $14.65 | +398.29% | 4 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $18.98 | +179.24% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.48 | +521.12% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.32 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.19 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.23 | +225.20% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $5.34 | +12.36% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.40 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $21.26 | +144.65% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.55 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $14.00 | +100.00% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $162.88 | +22.79% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $258.83 | +35.22% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $132.60 | -1.96% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $54.41 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $83.35 | +53.57% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $13.92 | +7.76% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $52.73 | +72.58% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.62 | +138.37% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $6.76 | +676.63% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $16.77 | - | 3 | Apr 2, 2020 |
Globus Medical
Dec 12, 2024
Maintains: Buy
Price Target: $87 → $91
Current: $70.49
Upside: +29.10%
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $39.24
Upside: +68.20%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $294.17
Upside: -8.22%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $86.86
Upside: +71.54%
Intuitive Surgical
Nov 26, 2024
Maintains: Buy
Price Target: $535 → $561
Current: $531.82
Upside: +5.49%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $381.56
Upside: +3.26%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $1.26
Upside: +693.65%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $97.38
Upside: +8.85%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $13.28
Upside: -
Zimmer Biomet Holdings
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $90.48
Upside: +39.26%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $69.37
Upside: +44.15%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $66.89
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $72 → $73
Current: $14.65
Upside: +398.29%
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $18.98
Upside: +179.24%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.48
Upside: +521.12%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.32
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.19
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $1.23
Upside: +225.20%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $5.34
Upside: +12.36%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $8.40
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $21.26
Upside: +144.65%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $13.55
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $14.00
Upside: +100.00%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $162.88
Upside: +22.79%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $258.83
Upside: +35.22%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $132.60
Upside: -1.96%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $54.41
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $83.35
Upside: +53.57%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $13.92
Upside: +7.76%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $52.73
Upside: +72.58%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.62
Upside: +138.37%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $6.76
Upside: +676.63%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $16.77
Upside: -